IST:ANGEN (Turkey)
Â
₺
12.01
(+0.33%)
May 31
Current and historical daily PE Ratio for Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (
) from 2021 to Jun 01 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve stock (IST:ANGEN) PE ratio as of Jun 01 2024 is 12.63.
More Details
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) PE Ratio (TTM) Chart
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 672
- 1
- 2
- 3
- 4
- 5
- 6
- 8
| Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirmenayi Ve PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-01 | 12.6 | 2024-03-22 | 13.2 |
| 2024-05-31 | 12.6 | 2024-03-21 | 13.3 |
| 2024-05-30 | 12.6 | 2024-03-20 | 13.4 |
| 2024-05-29 | 12.7 | 2024-03-19 | 13.5 |
| 2024-05-28 | 13.0 | 2024-03-18 | 13.4 |
| 2024-05-27 | 12.9 | 2024-03-15 | 13.8 |
| 2024-05-24 | 13.2 | 2024-03-14 | 13.8 |
| 2024-05-23 | 13.5 | 2024-03-13 | 13.8 |
| 2024-05-22 | 13.7 | 2024-03-12 | 14.0 |
| 2024-05-21 | 13.4 | 2024-03-11 | 14.3 |
| 2024-05-20 | 14.2 | 2024-03-08 | 14.6 |
| 2024-05-17 | 13.9 | 2024-03-07 | 14.5 |
| 2024-05-16 | 13.8 | 2024-03-06 | 14.0 |
| 2024-05-15 | 13.9 | 2024-03-05 | 14.7 |
| 2024-05-14 | 13.8 | 2024-03-04 | 14.3 |
| 2024-05-13 | 13.6 | 2024-03-01 | 14.3 |
| 2024-05-10 | 14.4 | 2024-02-29 | 14.2 |
| 2024-05-09 | 14.6 | 2024-02-28 | 14.1 |
| 2024-05-08 | 15.0 | 2024-02-27 | 14.2 |
| 2024-05-07 | 14.9 | 2024-02-26 | 14.6 |
| 2024-05-06 | 15.2 | 2024-02-23 | 14.7 |
| 2024-05-03 | 15.0 | 2024-02-22 | 14.9 |
| 2024-05-02 | 14.2 | 2024-02-21 | 14.7 |
| 2024-04-30 | 14.0 | 2024-02-20 | 15.0 |
| 2024-04-29 | 14.1 | 2024-02-19 | 14.8 |
| 2024-04-26 | 14.7 | 2024-02-16 | 15.3 |
| 2024-04-25 | 14.9 | 2024-02-15 | 15.1 |
| 2024-04-24 | 14.8 | 2024-02-14 | 14.9 |
| 2024-04-22 | 14.8 | 2024-02-13 | 14.5 |
| 2024-04-19 | 14.4 | 2024-02-12 | 15.1 |
| 2024-04-18 | 14.3 | 2024-02-09 | 14.9 |
| 2024-04-17 | 14.4 | 2024-02-08 | 15.0 |
| 2024-04-16 | 14.1 | 2024-02-07 | 14.8 |
| 2024-04-15 | 14.4 | 2024-02-06 | 14.6 |
| 2024-04-08 | 14.6 | 2024-02-05 | 14.6 |
| 2024-04-05 | 13.8 | 2024-02-02 | 14.7 |
| 2024-04-04 | 13.5 | 2024-02-01 | 14.6 |
| 2024-04-03 | 12.8 | 2024-01-31 | 14.4 |
| 2024-04-02 | 13.3 | 2024-01-30 | 14.1 |
| 2024-04-01 | 13.1 | 2024-01-29 | 14.3 |
| 2024-03-29 | 13.2 | 2024-01-26 | 14.4 |
| 2024-03-28 | 13.0 | 2024-01-25 | 14.2 |
| 2024-03-27 | 13.0 | 2024-01-24 | 14.0 |
| 2024-03-26 | 12.8 | 2024-01-23 | 14.0 |
| 2024-03-25 | 13.1 | 2024-01-22 | 14.4 |
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve (IST:ANGEN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve
ISIN : TREANGN00028
Description
Anatolia Tani Ve Biyoteknoloji Urunleri Arastirma Gelistirme Sanayi Ve Ticaret AS is an international biotechnology company. It is engaged in designing, developing, and manufacturing Real-Time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments. It also manufactures NA Extraction kits, Microbiology kits, Genetic Disorders kits, Panel kits, Sequencing kits, Food Testing kits.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers